Cervical dysplasia, also known as
cervical intraepithelial neoplasia (CIN), is a premalignant transformation,
which is characterized by abnormal growth of cells over the surface of the
cervix. This condition is curable and is not considered as cancer and ranges
from mild to severe forms depending upon the concentration of abnormal cell
formation. However, sometimes this disease may not require intervention and
can eliminate on its own due to strong immune response, and if left untreated
it may also lead to cervical cancer.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/cervical-dysplasia-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Chronic form of cervical dysplasia
is mainly caused due to infection of the cervix with sexually transmitted
human papilloma viruses, especially through its 16 and 18 types. This disease
is very common among females of age between 25 to 35 years of age, but it can
affect women of all age groups. Cervical dysplasia can also be caused in
people having multiple sex partners, early pregnancy or early child birth, and
other illnesses and is often devoid of any visible symptoms, but it can be
detected via human papilloma virus DNA test. Cervical dysplasia can be treated
via monotherapy or combination drugs, ablation therapy and resection (removal
of the abnormal area) therapy. On the basis of the degree of the condition the
cervical dysplasia market can be classified into three major segments namely,
mild dysplasia (CIN1), moderate dysplasia (CIN2) and severe dysplasia to
cancer (CIN3).
Major driving factors for the
growth of cervical dysplasia market include, increasing occurrences of various
sexually transmitted diseases (STDs), increasing smoking habits, alcohol and
drug abuse, increasing usage of immunosuppressant drugs and others. The
increasing prevalence of various STDs has considerably increased the chances
of occurrence of several mild to severe forms of cervical dysplasia. Moreover,
increasing prevalence of CIN, thus can also lead to cervical cancer, where
mild and severe CIN can be treated via several therapeutic procedures, thus
contributing towards the growth of this market. Increasing use of tobacco,
smoking and drug abuse also increase the chances of contracting this disease,
and global rise in smoking habits will also contribute towards this market’s
growth. Increasing disease forms have led to growth in usage of various drugs
including immunosuppressants that can rise in the risk of contracting this
disease. Recent technological advancements in therapeutic procedures for treating
various forms of this disease have also caused an increased demand world over,
which will continue to contribute towards the growth of cervical dysplasia
treatments market.
Geographically, North America
dominates the cervical dysplasia market followed by Europe. Major factors
responsible for the dominance of these regions over other markets were high
awareness levels among people about the disease and its treatments as well as
well-established healthcare infrastructure in these regions. Asia-Pacific
region holds immense potential for growth as this region shown the fastest
growth in the segment. Major factors responsible for this region’s fast rate
of growth were increasing disease occurrences and increasing awareness about
the disease and its treatments. Demand for advanced treatment options, current
advancements and the ongoing clinical trials to enhance the therapeutics for
the disease will also contribute towards the growth of Asia-Pacific cervical
dysplasia treatments market. Some of the key players operating in the cervical
dysplasia market are Advaxis, Inc., AnGes MG, Inc., Eisai, Inc., GlaxoSmithKline
plc, Inovio Biomedical Corporation, and Photocure ASA.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for
upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking perspective
on different factors driving or restraining market growth
- It provides a technological
growth map over time to understand the industry growth rate
- It provides a seven-year
forecast assessed on the basis of how the market is predicted to
grow
- It helps in understanding the
key product segments and their future
- It provides pin point analysis
of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed
business decisions by having complete insights of market and by making
in-depth analysis of market segments
- It provides distinctive
graphics and exemplified SWOT analysis of major market segments
Office: United States
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment